Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ASLAN Pharmaceuticals Pte Ltd

Latest From ASLAN Pharmaceuticals Pte Ltd

After Long Regulatory Run, Sanofi’s Dupixent Set To Transform India AD Market

Sanofi has received a go-ahead in India for dupilumab in atopic dermatitis with a trial waiver. An India-specific price, local real-world effectiveness and safety study and compelling data are expected to give it an edge over competition in the wings, including Pfizer’s Cibinq.

Commercial Business Strategies

Aslan Bullish On Once-Monthly Dosing For Eblasakimab In Atopic Dermatitis

A Phase IIb trial testing the IL-13 inhibitor in atopic dermatitis demonstrated solid efficacy when dosed once every four weeks, but the market is competitive and dominated by Sanofi/Regeneron’s Dupixent.

Clinical Trials Business Strategies

Deal Watch: Tourmaline Will Pursue Its Thyroid Eye Disease Ambitions Following Merger With Talaris

Plus deals involving ASLAN/Zenyaku Kogyo, AstraZeneca/Cholsegen, Astellas/Cullgen, AbCellera/Confo, Blue Water/WraSer, Solve/Cereius, Prime Medicine/Cimeio, Evox/Codiak, PharmaTher/Vitruvias and Adverum/Ray.

Deal Watch Business Strategies

'Still Bad Out There' - Drug Makers In APAC Prepare For Worst Before It Gets Better

Cross-border deals are down and investment has dried up, while geopolitical tensions have started hitting the Chinese biotech sector in unprecedented ways. Biopharma firms are expecting more rainy days ahead and are embracing new fundraising and deal-making approaches to survive and thrive.

China Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies